Using Intelligent Automation to Create a Healthier Life Sciences Supply Chain
The pharmaceutical industry has grown rapidly over the last decade due to an aging population in developed countries and the ongoing expansion into emerging markets, including parts of Africa, Asia and Latin America. With today’s top drug makers being huge, highly complex conglomerates located across multiple geographic regions, technology change in the industry has been slow in comparison, creating an environment that is ripe for supply chain automation.
Further complicating the situation has been the introduction of new global regulations like the FDA’s Drug Supply Chain Security Act. Despite the disruption caused by phenomena like new technologies and regulations, however, pharma organizations should not see them as a threat if they provide the opportunity to improve the supply chain and overall value chain via technological innovation.
This white paper explores how life sciences companies can enable supply chain automation through the application of technologies that leverage artificial intelligence to eliminate manual tasks and increase efficiency. Covering key use cases like cognitive document processing and supply chain visibility, the paper focuses on the viability of robotic process automation (RPA) and intelligent automation (IA) in particular.
Download the white paper now to get our view on how IA and RPA technologies can be applied to enable supply chain automation in life sciences.